SCHEMBL7423380

SCHEMBL7423380

COC(=O)c1cc(C)c2c(CCC(=O)O)n[nH]c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.39
▸ KDM4E B2RXH2 4/20 0.37
▸ PARP1 P09874 2/20 0.36
▸ GPR17 Q13304 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HPGD P15428 3/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAP2K4 P45985 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PPARA Q07869 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ AR P10275 1/20 0.34
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421945 0.84 PARP1 (0.36) ALDH1A1KDM4EPARP1TDP1POLB
SCHEMBL7425752 0.84 KDM4E (0.36) ALDH1A1KDM4EPARP1NPSR1SMN1; SMN2
SCHEMBL7428711 0.76 BACE1 (0.43) ALDH1A1KDM4EPARP1HPGDSMN1; SMN2
SCHEMBL1495964 0.67 NPSR1 (0.56) ALDH1A1KDM4ENPSR1HPGDTDP1
SCHEMBL8572190 0.67 AR (0.49) ALDH1A1KDM4ENPSR1HPGDTDP1
SCHEMBL28572614 0.64 TDO2 (0.51) ALDH1A1KDM4EPARP1HPGDTDP1
SCHEMBL5552600 0.64 NPSR1 (0.51) ALDH1A1KDM4ENPSR1HPGDTDP1
SCHEMBL15417877 0.64 KDM4E (0.38) ALDH1A1KDM4EPARP1HTTTDP1
SCHEMBL13132281 0.64 MAP2K4 (0.43) ALDH1A1KDM4ETDP1POLBMAP2K4
SCHEMBL3603266 0.64 MAP2K4 (0.52) ALDH1A1KDM4EPARP1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054871-A2 PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-29 — — EP disclosed
WO-1999050249-A2 PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-07 — — WO disclosed
Send feedback